Randomized Exercise Trial of Aromatase Inhibitor–Induced Arthralgia in Breast Cancer Survivors

PURPOSE: Arthralgia occurs in up to 50% of breast cancer survivors treated with aromatase inhibitors (AIs) and is the most common reason for poor AI adherence. We conducted, in 121 breast cancer survivors receiving an AI and reporting arthralgia, a yearlong randomized trial of the impact of exercise...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Irwin, Melinda L., Cartmel, Brenda, Gross, Cary P., Ercolano, Elizabeth, Li, Fangyong, Yao, Xiaopan, Fiellin, Martha, Capozza, Scott, Rothbard, Marianna, Zhou, Yang, Harrigan, Maura, Sanft, Tara, Schmitz, Kathryn, Neogi, Tuhina, Hershman, Dawn, Ligibel, Jennifer
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2015
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4372849/
https://ncbi.nlm.nih.gov/pubmed/25452437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.57.1547
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados